Testosterone prodrug (Lipocine)

睾酮前药 (Lipocine)

Report date: 2024/12/30 11:27:47

Base Information

Drug NameTestosterone prodrug (Lipocine)
Drug Alias NameLPCN-1144
ClassificationSmall molecules > Steroids
Mechanisms of ActionAndrogen Receptor agonistsTestosterone replacements
TargetsAndrogen Receptor
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLipocine Inc
China Registration ClassN/A

Develop Information

Active CompaniesLipocine Inc
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A